Amedeo Smart

Free Medical Literature Service




  Free Subscription


2 Clin Infect Dis
2 Infect Immun
3 J Infect Dis
1 J Virol
1 MMWR Morb Mortal Wkly Rep
1 Nat Med
3 Pediatr Infect Dis J
2 PLoS Med
5 PLoS One
1 Proc Natl Acad Sci U S A
1 Science
9 Vaccine
1 Virus Res


  1. CHAMMARTIN F, Kusejko K, Pasin C, Trkola A, et al
    Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV.
    AIDS. 2022;36:1465-1468.
    >> Share


  2. SAXENA S, Skirrow H, Wighton K
    Vaccinating children aged under 5 years against covid-19.
    BMJ. 2022;378:o1863.
    >> Share

    Clin Infect Dis

  3. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    >> Share

  4. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    >> Share

    Infect Immun

  5. MAJUMDER S, Olson RM, Singh A, Wang X, et al
    Protection Induced by Oral Vaccination with a Recombinant Yersinia pseudotuberculosis Delivering Yersinia pestis LcrV and F1 Antigens in Mice and Rats against Pneumonic Plague.
    Infect Immun. 2022 Jul 28:e0016522. doi: 10.1128/iai.00165.
    >> Share

  6. BASSET A, Wall E, Mitsi E, Deshusses C, et al
    Targeted Transcriptomic Screen of Pneumococcal Genes Expressed during Murine and Human Infection.
    Infect Immun. 2022;90:e0017522.
    >> Share

    J Infect Dis

  7. KNOLL MD, Bennett JC, Yang Y, Quesada MG, et al
    Challenges inferring pneumococcal conjugate vaccine impact from bacterial surveillance data.
    J Infect Dis. 2022 Jul 28. pii: 6650942. doi: 10.1093.
    >> Share

  8. CHU WM, Lee YH, Cheng-Chung Wei J, Lee YH, et al
    Comment on Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults.
    J Infect Dis. 2022 Jul 26. pii: 6649924. doi: 10.1093.
    >> Share

  9. CRISTINA CASSETTI M, Pierson TC, Jean Patterson L, Bok K, et al
    Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness.
    J Infect Dis. 2022 Jul 25. pii: 6649664. doi: 10.1093.
    >> Share

    J Virol

  10. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    >> Share

    MMWR Morb Mortal Wkly Rep

  11. HAUSE AM, Baggs J, Marquez P, Abara WE, et al
    Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged >/=50 Years - United States, March 29, 2022-July 10, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:971-976.
    >> Share

    Nat Med

  12. JARA A, Undurraga EA, Zubizarreta JR, Gonzalez C, et al
    Effectiveness of CoronaVac in children 3-5 years of age during the SARS-CoV-2 Omicron outbreak in Chile.
    Nat Med. 2022;28:1377-1380.
    >> Share

    Pediatr Infect Dis J

  13. SYROGIANNOPOULOS GA, Michoula AN, Grivea IN
    Global Epidemiology of Vaccine-preventable Bacterial Meningitis.
    Pediatr Infect Dis J. 2022 Jul 27. pii: 00006454-990000000-00146.
    >> Share

  14. OHNISHI Y, Okada S, Kawakami-Miyake A, Furuta T, et al
    Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations.
    Pediatr Infect Dis J. 2022 Jul 27. pii: 00006454-990000000-00145.
    >> Share

  15. MCMILLAN M, Bednarz J, Leong LEX, Lawrence A, et al
    Impact of COVID-19 Containment Strategies and Meningococcal Conjugate ACWY Vaccination on Meningococcal Carriage in Adolescents.
    Pediatr Infect Dis J. 2022 Jul 27. pii: 00006454-990000000-00144.
    >> Share

    PLoS Med

  16. MASSARI M, Spila Alegiani S, Morciano C, Spuri M, et al
    Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    PLoS Med. 2022;19:e1004056.
    >> Share

  17. HERNANDEZ I, Dickson S, Tang S, Gabriel N, et al
    Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    PLoS Med. 2022;19:e1004069.
    >> Share

    PLoS One

  18. KHOKHAR F, Pickard D, Dyson Z, Iqbal J, et al
    Multiplex PCR assay to detect high risk lineages of Salmonella Typhi and Paratyphi A.
    PLoS One. 2022;17:e0267805.
    >> Share

  19. GOTO T, Tani N, Ikematsu H, Gondo K, et al
    Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
    PLoS One. 2022;17:e0272056.
    >> Share

  20. HWANG J, Su MH, Jiang X, Lian R, et al
    Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy.
    PLoS One. 2022;17:e0271394.
    >> Share

  21. KADYROVA I, Yegorov S, Negmetzhanov B, Kolesnikova Y, et al
    High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination.
    PLoS One. 2022;17:e0272008.
    >> Share

  22. TRAJMAN A, Lachapelle-Chisholm S, Zikos T, Werneck GL, et al
    Efficacy and effectiveness of SARS-CoV-2 vaccines for death prevention: A protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0265414.
    >> Share

    Proc Natl Acad Sci U S A

  23. ZHANG Y, Lu M, Mahesh KC, Kim E, et al
    A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2022;119:e2201616119.
    >> Share


  24. DOLGIN E
    The ascent of ModernaThe Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World Peter Loftus Harvard Business Review Press, 2022. 320 pp.
    Science. 2022;377:479.
    >> Share


  25. PRIDDY FH, Williams M, Carson S, Lavender B, et al
    Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.
    Vaccine. 2022 Jul 12. pii: S0264-410X(22)00885.
    >> Share

  26. LORENZETTI L, Haydarov R, Namey E, Lawton A, et al
    Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria.
    Vaccine. 2022 Jul 20. pii: S0264-410X(22)00591.
    >> Share

  27. MCADAMS D, Estrada M, Holland D, Singh J, et al
    Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency.
    Vaccine. 2022 Jul 21. pii: S0264-410X(22)00892.
    >> Share

  28. SETHY G, Chisema M, Sharma L, Joshi K, et al
    COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach.
    Vaccine. 2022 Jul 18. pii: S0264-410X(22)00887.
    >> Share

  29. PAWASKAR M, Gil-Rojas Y, Irene Parellada C, Rey-Velasco A, et al
    The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008-2019.
    Vaccine. 2022 Jul 21. pii: S0264-410X(22)00889.
    >> Share

  30. SIMSEK C, Bloemen M, Jansen D, Descheemaeker P, et al
    Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis.
    Vaccine. 2022 Jul 21. pii: S0264-410X(22)00853.
    >> Share

  31. CHANG MJ, Ollivault-Shiflett M, Schuman R, Ngoc Nguyen S, et al
    Genetically detoxified tetanus toxin as a vaccine and conjugate carrier protein.
    Vaccine. 2022 Jul 21. pii: S0264-410X(22)00886.
    >> Share

  32. MCMILLAN CLD, Amarilla AA, Modhiran N, Choo JJY, et al
    Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern.
    Vaccine. 2022 Jul 18. pii: S0264-410X(22)00888.
    >> Share

  33. SPENCER CLINTON JL, Hoornweg TE, Tan J, Peng R, et al
    EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice.
    Vaccine. 2022 Jul 22. pii: S0264-410X(22)00891.
    >> Share

    Virus Res

  34. LEGNARDI M, Cecchinato M, Homonnay Z, Dauphin G, et al
    Viral subpopulation variability in different batches of Infectious bronchitis virus (IBV) vaccines based on GI-23 lineage: implications for the field.
    Virus Res. 2022 Jul 21:198877. doi: 10.1016/j.virusres.2022.198877.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016